Benjamin Dehay - Related publications

Université de Bordeaux, Talence, Nouvelle-Aquitaine, France 
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2021 Follett J, Farrer MJ. LRRK2; a dynamic regulator of cellular trafficking. Brain Research. 1761: 147394. PMID 33662339 DOI: 10.1016/j.brainres.2021.147394   
2021 Stojkovska I, Mazzulli JR. Detection of pathological alpha-synuclein aggregates in human iPSC-derived neurons and tissue. Star Protocols. 2: 100372. PMID 33733241 DOI: 10.1016/j.xpro.2021.100372   
2021 He S, Wang F, Yung KKL, Zhang S, Qu S. Effects of α-Synuclein-Associated Post-Translational Modifications in Parkinson's Disease. Acs Chemical Neuroscience. PMID 33769791 DOI: 10.1021/acschemneuro.1c00028   
2021 Tong Q, Chen L. Associations of Alzheimer's Disease Neuropathologic Changes with Clinical Presentations of Parkinson's Disease. Journal of Alzheimer's Disease : Jad. PMID 33720903 DOI: 10.3233/JAD-210114   
2021 Terracciano A, Aschwanden D, Stephan Y, Cerasa A, Passamonti L, Toschi N, Sutin AR. Neuroticism and Risk of Parkinson's Disease: A Meta-Analysis. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33817817 DOI: 10.1002/mds.28575   
2021 Ajoolabady A, Aslkhodapasandhokmabad H, Henninger N, Demillard LJ, Nikanfar M, Nourazarian A, Ren J. Targeting Autophagy in Neurodegenerative Diseases: from Molecular Mechanisms to Clinical Therapeutics. Clinical and Experimental Pharmacology & Physiology. PMID 33752254 DOI: 10.1111/1440-1681.13500   
2021 Tavassoly O, Del Cid Pellitero E, Larroquette F, Cai E, Thomas RA, Soubannier V, Luo W, Durcan TM, Fon EA. Pharmacological Inhibition of Brain EGFR Activation By a BBB-penetrating Inhibitor, AZD3759, Attenuates α-synuclein Pathology in a Mouse Model of α-Synuclein Propagation. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 33713002 DOI: 10.1007/s13311-021-01017-6   
2021 Nam Y, Moon GJ, Kim SR. Therapeutic Potential of AAV1-Rheb(S16H) Transduction against Neurodegenerative Diseases. International Journal of Molecular Sciences. 22. PMID 33802760 DOI: 10.3390/ijms22063064   
2021 Henderson MX, Changolkar L, Trojanowski JQ, Lee VMY. LRRK2 Kinase Activity Does Not Alter Cell-Autonomous Tau Pathology Development in Primary Neurons. Journal of Parkinson's Disease. PMID 33720852 DOI: 10.3233/JPD-212562   
2021 Falabella M, Vernon HJ, Hanna MG, Claypool SM, Pitceathly RDS. Cardiolipin, Mitochondria, and Neurological Disease. Trends in Endocrinology and Metabolism: Tem. PMID 33640250 DOI: 10.1016/j.tem.2021.01.006   
2021 Streubel-Gallasch L, Giusti V, Sandre M, Tessari I, Plotegher N, Giusto E, Masato A, Iovino L, Battisti I, Arrigoni G, Shimshek D, Greggio E, Tremblay ME, Bubacco L, Erlandsson A, et al. Parkinson's Disease-Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance. Molecular Neurobiology. PMID 33629273 DOI: 10.1007/s12035-021-02327-8   
2021 Brás IC, Outeiro TF. Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies. Cells. 10. PMID 33673034 DOI: 10.3390/cells10020375   
2021 Kim R, Park S, Yoo D, Jun JS, Jeon B. Association of Physical Activity and Genotype With Longitudinal Cognitive Change in Early PD. Neurology. PMID 33790041 DOI: 10.1212/WNL.0000000000011852   
2021 Antunes ASLM, de Almeida V, Crunfli F, Carregari VC, Martins-de-Souza D. Proteomics for Target Identification in Psychiatric and Neurodegenerative Disorders. Advances in Experimental Medicine and Biology. 1286: 251-264. PMID 33725358 DOI: 10.1007/978-3-030-55035-6_17   
2021 Riley EA, Schekman R. Open science takes on Parkinson's disease. Elife. 10. PMID 33629954 DOI: 10.7554/eLife.66546   
2021 Ravanfar P, Loi SM, Syeda WT, Van Rheenen TE, Bush AI, Desmond P, Cropley VL, Lane DJR, Opazo CM, Moffat BA, Velakoulis D, Pantelis C. Systematic Review: Quantitative Susceptibility Mapping (QSM) of Brain Iron Profile in Neurodegenerative Diseases. Frontiers in Neuroscience. 15: 618435. PMID 33679303 DOI: 10.3389/fnins.2021.618435   
2021 Wells C, Brennan S, Keon M, Ooi L. The role of amyloid oligomers in neurodegenerative pathologies. International Journal of Biological Macromolecules. PMID 33766600 DOI: 10.1016/j.ijbiomac.2021.03.113   
2021 Singh A, Agrawal N. Deciphering the key mechanisms leading to alteration of lipid metabolism in Drosophila model of Huntington's disease. Biochimica Et Biophysica Acta. Molecular Basis of Disease. 166127. PMID 33722743 DOI: 10.1016/j.bbadis.2021.166127   
2021 Shill HA, Zhang N, Driver-Dunckley E, Mehta S, Adler CH, Beach TG. Olfaction in Neuropathologically Defined Progressive Supranuclear Palsy. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33755262 DOI: 10.1002/mds.28568   
2021 Jiang C, Hopfner F, Berg D, Hu MT, Pilotto A, Borroni B, Davis JJ, Tofaris GK. Validation of α-Synuclein in L1CAM-Immunocaptured Exosomes as a Biomarker for the Stratification of Parkinsonian Syndromes. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33826157 DOI: 10.1002/mds.28591   
2021 Reyes JF, Ekmark-Léwen S, Perdiki M, Klingstedt T, Hoffmann A, Wiechec E, Nilsson P, Nilsson KPR, Alafuzoff I, Ingelsson M, Hallbeck M. Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson's disease. Acta Neuropathologica Communications. 9: 46. PMID 33743820 DOI: 10.1186/s40478-021-01136-3   
2021 Holbrook JA, Jarosz-Griffiths HH, Caseley E, Lara-Reyna S, Poulter JA, Williams-Gray CH, Peckham D, McDermott MF. Neurodegenerative Disease and the NLRP3 Inflammasome. Frontiers in Pharmacology. 12: 643254. PMID 33776778 DOI: 10.3389/fphar.2021.643254   
2021 Kubota S, Doi H, Koyano S, Tanaka K, Komiya H, Katsumoto A, Ikeda S, Hashiguchi S, Nakamura H, Fukai R, Takahashi K, Kunii M, Tada M, Takeuchi H, Tanaka F. SGTA associates with intracellular aggregates in neurodegenerative diseases. Molecular Brain. 14: 59. PMID 33757575 DOI: 10.1186/s13041-021-00770-1   
2021 Chen X, Zhang Y, Wang Q, Qin Y, Yang X, Xing Z, Shen Y, Wu H, Qi Y. The function of SUMOylation and its crucial roles in the development of neurological diseases. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 35: e21510. PMID 33710677 DOI: 10.1096/fj.202002702R   
2021 Pingale TD, Gupta GL. Novel therapeutic approaches for Parkinson's disease by targeting brain cholesterol homeostasis. The Journal of Pharmacy and Pharmacology. PMID 33822122 DOI: 10.1093/jpp/rgaa063   
2021 Xing J, Xu C. Role of connexins in neurodegenerative diseases (Review). Molecular Medicine Reports. 23. PMID 33760195 DOI: 10.3892/mmr.2021.12034   
2021 Inoue K. CRISPR-activated patient fibroblasts for modeling of familial Alzheimer's disease. Neuroscience Research. PMID 33819561 DOI: 10.1016/j.neures.2021.03.008   
2021 Girges C, Vijiaratnam N, Athauda D, Auld G, Gandhi S, Foltynie T. The Future of Incretin-Based Approaches for Neurodegenerative Diseases in Older Adults: Which to Choose? A Review of their Potential Efficacy and Suitability. Drugs & Aging. PMID 33738783 DOI: 10.1007/s40266-021-00853-7   
2021 Gu H, Yang X, Mao X, Xu E, Qi C, Wang H, Brahmachari S, York B, Sriparna M, Li A, Chang M, Patel P, Dawson VL, Dawson TM. Lymphocyte Activation Gene 3 (Lag3) Contributes to α-Synucleinopathy in α-Synuclein Transgenic Mice. Frontiers in Cellular Neuroscience. 15: 656426. PMID 33776654 DOI: 10.3389/fncel.2021.656426   
2021 Kawakami I, Motoda A, Hashimoto M, Shimozawa A, Masuda-Suzukake M, Ohtani R, Takase M, Kumashiro M, Samejima K, Hasegawa M. Progression of phosphorylated α-synuclein in Macaca fuscata. Brain Pathology (Zurich, Switzerland). e12952. PMID 33754430 DOI: 10.1111/bpa.12952   
2021 Pagonabarraga J, Horta-Barba A, Busteed L, Bejr-Kasem H, Illán-Gala I, Aracil-Bolaños I, Marín-Lahoz J, Pascual-Sedano B, Pérez J, Campolongo A, Izquierdo C, Martinez-Horta S, Sampedro F, Kulisevsky J. Quantitative evaluation of oculomotor disturbances in progressive supranuclear palsy. Parkinsonism & Related Disorders. 85: 63-68. PMID 33744691 DOI: 10.1016/j.parkreldis.2021.03.002   
2021 Roshanbin S, Aniszewska A, Gumucio A, Masliah E, Erlandsson A, Bergström J, Ingelsson M, Ekmark-Lewén S. Age-related increase of alpha-synuclein oligomers is associated with motor disturbances in L61 transgenic mice. Neurobiology of Aging. 101: 207-220. PMID 33639338 DOI: 10.1016/j.neurobiolaging.2021.01.010   
2021 Liu X, Yin L, Li T, Lin L, Zhang J, Li Y. Reduction of WDR81 impairs autophagic clearance of aggregated proteins and cell viability in neurodegenerative phenotypes. Plos Genetics. 17: e1009415. PMID 33730050 DOI: 10.1371/journal.pgen.1009415   
2021 Ghosh P, Saadat A. Neurodegeneration and epigenetics: A review. Neurologia (Barcelona, Spain). PMID 33712337 DOI: 10.1016/j.nrl.2021.01.016   
2021 Tunold JA, Geut H, Rozemuller JMA, Henriksen SP, Toft M, van de Berg WDJ, Pihlstrøm L. and Are Associated With Dementia in Neuropathologically Confirmed Parkinson's Disease. Frontiers in Neurology. 12: 631145. PMID 33613437 DOI: 10.3389/fneur.2021.631145   
2021 Fu L, Wu SS. Advances in studies on exosomes and microvesicles as markers of cardiovascular disease. European Review For Medical and Pharmacological Sciences. 25: 2622-2629. PMID 33829449 DOI: 10.26355/eurrev_202103_25426   
2021 Fiolek TJ, Keel KL, Tepe JJ. Fluspirilene Analogs Activate the 20S Proteasome and Overcome Proteasome Impairment by Intrinsically Disordered Protein Oligomers. Acs Chemical Neuroscience. PMID 33788542 DOI: 10.1021/acschemneuro.1c00099   
2021 Nardini E, Hogan R, Flamier A, Bernier G. Alzheimer's disease: a tale of two diseases? Neural Regeneration Research. 16: 1958-1964. PMID 33642366 DOI: 10.4103/1673-5374.308070   
2021 Pan Q, Ban Y, Khan S. Antioxidant activity of calycosin against α-synuclein amyloid fibrils-induced oxidative stress in neural-like cells as a model of preventive care studies in Parkinson's disease. International Journal of Biological Macromolecules. PMID 33798579 DOI: 10.1016/j.ijbiomac.2021.03.186   
2021 Root J, Merino P, Nuckols A, Johnson M, Kukar T. Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis. Neurobiology of Disease. 105360. PMID 33812000 DOI: 10.1016/j.nbd.2021.105360   
2021 Mc Ardle R, Pratt S, Buckley C, Del Din S, Galna B, Thomas A, Rochester L, Alcock L. Balance Impairments as Differential Markers of Dementia Disease Subtype. Frontiers in Bioengineering and Biotechnology. 9: 639337. PMID 33777910 DOI: 10.3389/fbioe.2021.639337   
2021 Meisl G, Kurt T, Condado-Morales I, Bett C, Sorce S, Nuvolone M, Michaels TCT, Heinzer D, Avar M, Cohen SIA, Hornemann S, Aguzzi A, Dobson CM, Sigurdson CJ, Knowles TPJ. Scaling analysis reveals the mechanism and rates of prion replication in vivo. Nature Structural & Molecular Biology. PMID 33767451 DOI: 10.1038/s41594-021-00565-x   
2021 Lopez-Lee C, Kodama L, Gan L. Sex Differences in Neurodegeneration: The Role of the Immune System in Humans. Biological Psychiatry. PMID 33715827 DOI: 10.1016/j.biopsych.2021.01.002   
2021 Banerjee A, Pradhan LK, Sahoo PK, Jena KK, Chauhan NR, Chauhan S, Das SK. Unravelling the potential of gut microbiota in sustaining brain health and their current prospective towards development of neurotherapeutics. Archives of Microbiology. PMID 33763767 DOI: 10.1007/s00203-021-02276-9   
2021 Sukhavasi SB, Sukhavasi SB, Elleithy K, Abuzneid S, Elleithy A. Human Body-Related Disease Diagnosis Systems Using CMOS Image Sensors: A Systematic Review. Sensors (Basel, Switzerland). 21. PMID 33802718 DOI: 10.3390/s21062098   
2021 Bai Y, Su X, Piao L, Jin Z, Jin R. Involvement of Astrocytes and microRNA Dysregulation in Neurodegenerative Diseases: From Pathogenesis to Therapeutic Potential. Frontiers in Molecular Neuroscience. 14: 556215. PMID 33815055 DOI: 10.3389/fnmol.2021.556215   
2021 Zhou J, Wang B, Bin X, Xie C, Li B, Liu O, Tang Z. CircHIPK3: Key Player in Pathophysiology and Potential Diagnostic and Therapeutic Tool. Frontiers in Medicine. 8: 615417. PMID 33693013 DOI: 10.3389/fmed.2021.615417   
2021 Baik K, Yang JJ, Jung JH, Lee YH, Chung SJ, Yoo HS, Sohn YH, Lee PH, Lee JM, Ye BS. Structural connectivity networks in Alzheimer's disease and Lewy body disease. Brain and Behavior. e02112. PMID 33792194 DOI: 10.1002/brb3.2112   
2021 Baik K, Yang JJ, Jung JH, Lee YH, Chung SJ, Yoo HS, Sohn YH, Lee PH, Lee JM, Ye BS. Structural connectivity networks in Alzheimer's disease and Lewy body disease. Brain and Behavior. e02112. PMID 33792194 DOI: 10.1002/brb3.2112   
2021 Psol M, Darvas SG, Leite K, Mahajani SU, Bähr M, Kügler S. Dementia with Lewy bodies-associated ß-synuclein mutations V70M and P123H cause mutation-specific neuropathological lesions. Human Molecular Genetics. PMID 33760043 DOI: 10.1093/hmg/ddab036